Xebra Brands Ltd. announced that it has satisfied all conditions pursuant to its agreement with New Age Nanotech, to license its clinically-backed, patent pending cannabinoid emulsion technology, Solutech™; to transform cannabis extracts into shelf-stable clear and odourless, water-soluble forms, ideal for the infusion of beverages, edibles and topicals. Many options were evaluated globally for cannabinoid delivery IP, and Xebra identified only one that has undergone human testing - Solutech™. Xebra has fully paid the consideration for the right to produce and use Solutech™.

The agreement is effective immediately with an indefinite perpetual term, unless terminated under specific circumstances.